Welcome to our dedicated page for Life360 SEC filings (Ticker: LIFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Life360's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Life360's regulatory disclosures and financial reporting.
Life360, Inc. (LIF) insider Charles J. Prober filed a notice to sell 7,930 shares of common stock under Rule 144 through Fidelity Brokerage Services LLC. The planned sale has an aggregate market value of $334,011.60 against 81,480,369 shares of common stock outstanding, with an approximate sale date of September 14, 2026. The shares are to be issued via stock option exercise for cash and sold on NASDAQ.
Life360, Inc. (LIF) director Chris Hulls reported that on September 8, 2026, 7,545 shares of common stock were withheld by Life360 at a price of $44.17 per share to satisfy income tax withholding obligations related to the vesting and net settlement of previously reported RSUs, which is not a market sale of shares. Following this tax-withholding transaction, Hulls held 374,511 shares of common stock directly, including 119,673 RSUs and shares underlying Chess Depositary Interests converted at a 1:3 common stock to CDI ratio, and also had indirect ownership of 195,312 shares of common stock in each of three 2023 irrevocable trusts for Robin, Rose, and Mckenzie Hulls, representing shares underlying 585,938 CDIs.
Life360, Inc. (LIF) reported that Chief Executive Officer and director Lauren Antonoff had 6,291 shares of common stock withheld on September 8, 2026 to satisfy income tax withholding and remittance obligations arising from the vesting and net settlement of previously reported restricted stock units (RSUs). This is not a sale of shares into the market. After this tax-withholding transaction, Antonoff directly holds 282,360 shares of common stock, including 107,683 RSUs that each represent a contingent right to receive one share upon vesting.
Life360, Inc. (LIF) reported that Chief Financial Officer Russell John Burke had 5,314 shares of common stock withheld on September 8, 2026 to cover income tax obligations related to vesting restricted stock units, at a reference value of $44.17 per share. This was not an open-market sale; the shares were retained by the issuer for tax remittance. After this withholding, Burke held 100,977 shares directly, including 95,904 restricted stock units (RSUs) that may convert into common stock as they vest. He also held additional indirect positions through several trusts, including shares held by the Russell John Burke Revocable Trust & Jeanette L Calandra Revocable Trust as tenants in common and three separate trusts for which Jeanette Calandra serves as trustee, reflecting estate and wealth-planning arrangements rather than market transactions.
Life360, Inc. (LIF) director James Synge reported open-market sales of the company’s common stock, executed via CHESS Depositary Interests (CDIs) traded on the Australian Securities Exchange. On 2026-08-26, he sold 27,466 common-stock-equivalent shares at a weighted average price of $44.31 per share, with individual sale prices ranging from $44.169 to $44.557. On 2026-08-25, he sold 5,833 common-stock-equivalent shares at a weighted average price of $45.05 per share. The prices were derived from CDI trades using the 3:1 CDI-to-common-stock conversion ratio and exchange rates of 0.715 and 0.7182, respectively. Reported holdings include 4,600 RSUs, each representing one share of common stock upon vesting, and also include common stock underlying CDIs on the same 1:3 basis.
Life360, Inc. (LIF) filed a Form D for a private exempt offering of equity securities under Regulation D Rule 506(b). The notice is a new filing, with the first sale on 2026-08-10. The company reports $600,000 USD total amount sold and $0 USD remaining to be sold, indicating the offering was fully subscribed. The transaction is described as an offering made pursuant to an Asset Purchase Agreement. Life360 indicates a revenue range of over $100,000,000, placing it in the largest issuer size category on the form. No finders’ fees were paid in connection with the offering, with finders' fees disclosed as $0 USD.
Life360, Inc. (LIF) director Synge James reported option exercises and related share issuances on August 19, 2026. James exercised stock options for 12,203 shares of common stock at an exercise price of $13.35 per share and 21,769 shares at $8.19 per share, with the underlying options fully vested and exercisable. The transactions moved 33,972 shares from derivative (option) holdings into common stock. Footnotes state that reported direct ownership includes 4,600 RSUs and shares underlying Chess Depositary Interests, which trade on the Australian Securities Exchange.
Life360, Inc. (LIF) director Chris Hulls reported a series of option exercises and share sales on 2026-08-18. He exercised stock options for a total of 212,502 shares of common stock at exercise prices of $2.53, $7.28 and $8.19 per share, from fully vested options. On the same date he sold 250,000 shares of common stock in open-market transactions at weighted average prices of $46.78 and $47.58 per share, with individual sale prices ranging from $46.36–$48.30 per share. Following these transactions, indirect holdings of 195,312 shares of common stock are reported for each of three 2023 irrevocable trusts, which represent shares underlying Chess Depositary Interests.
Life360, Inc. (LIF) received a notice under Rule 144 that director Christopher Hulls, through an account at Fidelity Brokerage Services LLC, may sell up to 250,000 shares of common stock. These shares are tied to restricted stock vesting and stock option exercises scheduled between December 2025 and August 2026. The notice lists an aggregate market value of $11,708,952.38 for the 250,000 shares, based on trading on NASDAQ, with a stated trading volume of 81,480,369 shares as of August 18, 2026.
Life360, Inc. director Charles J. Prober exercised a fully vested stock option for 7,930 shares of common stock at an exercise price of $11.18 per share, leaving 23,790 option shares outstanding. He then sold 7,930 common shares at $48.59 per share on the same date. The transactions were executed under a Rule 10b5-1 trading plan adopted on March 14, 2025. Reported equity holdings include 4,474 restricted stock units, each representing one future share upon vesting.